Simon M. Poucher

Mereside, Alderley Park
Macclesfield, ENG SK104TG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Obesity and Cage Environment Modulate Metabolism in the Zucker Rat: A Multiple Biological Matrix Approach to Characterizing Metabolic Phenomena.

Obesity and Cage Environment Modulate Metabolism in the Zucker Rat: A Multiple Biological Matrix Approach to Characterizing Metabolic Phenomena.

Journal: Journal of proteome research

Published: April 04, 2019

Muscle carnitine availability plays a central role in regulating fuel metabolism in the rodent.

Muscle carnitine availability plays a central role in regulating fuel metabolism in the rodent.

Journal: The Journal of physiology

Published: March 29, 2017

Development of microdialysis methodology for interstitial insulin measurement in rodents.

Development of microdialysis methodology for interstitial insulin measurement in rodents.

Journal: Journal of pharmacological and toxicological methods

Published: December 11, 2016

Age and microenvironment outweigh genetic influence on the Zucker rat microbiome.

Age and microenvironment outweigh genetic influence on the Zucker rat microbiome.

Journal: PloS one

Published: January 16, 2014

Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus.

Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus.

Journal: Expert opinion on investigational drugs

Published: March 05, 2013

Variability in fasting lipid and glycogen contents in hepatic and skeletal muscle tissue in subjects with and without type 2 diabetes: a 1H and 13C MRS study.

Variability in fasting lipid and glycogen contents in hepatic and skeletal muscle tissue in subjects with and without type 2 diabetes: a 1H and 13C MRS study.

Journal: NMR in biomedicine

Published: February 06, 2013

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus.

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: August 28, 2012

Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor dapagliflozin.

Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor dapagliflozin.

Journal: Postgraduate medicine

Published: August 24, 2012

Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes.

Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes.

Journal: Digestive diseases and sciences

Published: January 05, 2012

Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes.

Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: November 16, 2011

An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.

An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.

Journal: British journal of pharmacology

Published: October 16, 2007

Showing 1-11 of 11

Last Updated: 09/26/2026